Barclays’s DermTech, Inc. Common Stock DMTK Stock Holding History

Barclays’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-97	Closed	-$68	–	5404
2024 Q1	$68	Hold	97	–	–	﹤0.01%	5004
2023 Q4	$170	Sell	97 -97	-50%	-$142	﹤0.01%	5156
2023 Q3	$280	Buy	194 +97	+100%	+$243	﹤0.01%	4525
2023 Q2	$252	Hold	97	–	–	﹤0.01%	4412
2023 Q1	$357	Hold	97	–	–	﹤0.01%	4961
2022 Q4	$172	Sell	97 -600	-86%	-$1.6K	﹤0.01%	5189
2022 Q3	$3K	Buy	+697	New	+$4.29K	﹤0.01%	4600
2022 Q2	–	Sell	-4,022	Closed	-$59K	–	5340
2022 Q1	$59K	Buy	+4,022	New	+$53.8K	﹤0.01%	4047

Other funds holding DMTK

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return

GWSA

Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return

T2I

Turim 21 Investimentos Rio De Janeiro, Brazil $399M AUM 20.13% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

Barclays's DMTK Position: Q2 2024 in Review

Barclays sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 97 shares — an estimated $68 sold.

Barclays first reported a position in DMTK in Q1 2022 and held it in 8 quarters. The position peaked at $59K in Q1 2022. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

Barclays reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Barclays sold 97 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $68.
Barclays first reported a position in DermTech, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
Barclays's DermTech, Inc. Common Stock position peaked at $59K in Q1 2022.
8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.